ArticlePharmacoEconomics2018
Economic Evaluation of Stiripentol for Dravet Syndrome: A Cost-Utility Analysis.
Jesse Elliott et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this paperpooled itcites it
ArticlePharmacoEconomics2018
Jesse Elliott et al.PubMed ↗Publisher ↗
No numbers read from the abstract.